Eledon Pharmaceuticals
ELDN
ELDN
30 hedge funds and large institutions have $14.7M invested in Eledon Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.08% less ownership
Funds ownership: 45.43% → 45.35% (-0.08%)
Holders
30
Holding in Top 10
–
Calls
$17K
Puts
$3K
Top Buyers
| 1 | +$72.7K | |
| 2 | +$35.4K | |
| 3 | +$30.7K | |
| 4 |
Millennium Management
New York
|
+$30K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.4K |
Top Sellers
| 1 | -$154K | |
| 2 | -$32.3K | |
| 3 | -$9.56K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8.34K |
| 5 |
Rockefeller Capital Management
New York
|
-$3K |